Information:
Fel:
Nyckelord
Vakzine, Hepatitis-B- ×
- Clinical Trial (47)
- Adverse event (47)
- Hepatitis B (27)
- Clinical Trial, Phase III (21)
- Vaccines (16)
- Drug-Related Side Effects and Adverse Reactions (13)
- Gastroenterology (13)
- Hepatitis A Vaccines (12)
- On-Study Form (11)
- Haemophilus influenzae type b (10)
- Vaccination (9)
- Signs and Symptoms (7)
- Diphtheria-Tetanus-Pertussis Vaccine (7)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (7)
- Meningitis, Haemophilus (6)
- Safety (5)
- Laboratories (5)
- Physical Examination (4)
- Fever (4)
- Tetanus (3)
- Bordetella pertussis (3)
- Meningococcal Vaccines (3)
- Symptom Assessment (3)
- Concomitant Medication (3)
- Diphtheria (3)
- Follow-Up Studies (3)
- Comparative Study (2)
- Appetite (1)
- Research Personnel (1)
- Vomiting (1)
- Adverse Drug Reaction Reporting Systems (1)
- Clinical Trial, Phase IV (1)
- Blood (1)
- Consent Forms (1)
- End of Study (1)
- Demography (1)
- Diarrhea (1)
- Hepatitis A (1)
- Immunologic Memory (1)
- Pain (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
47 Sökresultat.
Item-grupper: Administration, Follow-up studies, Study conclusion, Investigator signature, Tracking Document Safety Follow-Up, Tracking Document Safety Follow-Up , Serious adverse event safety follow-up - Administrative, Serious adverse event safety follow-up, Serious adverse event safety follow-up - Study vaccine information, Serious adverse event safety follow-up - Concomitant medication/ Vaccination that could have contributed to this SAE, Serious adverse event safety follow-up - Relevant intercurrent illness & medical history that could have contributed to this SAE , Serious adverse event safety follow-up - Drug(s) used to treat this SAE , Serious adverse event safety follow-up - Surgical treatment for this SAE , Serious adverse event safety follow-up - Description , Serious adverse event safety follow-up - Comments , Serious adverse event safety follow-up - Investigator signature
Item-grupper: Administration, Concomitant Vaccination, Concomitant Vaccination, Medication, Medication, Non-serious adverse events, Non-serious adverse events, Serious adverse event, Serious adverse event - Study vaccine information, Serious adverse event - Concomitant medication/ Vaccination that could have contributed to this SAE, Serious adverse event - Relevant intercurrent illness & medical history that could have contributed to this SAE, Serious adverse event - Drug(s) used to treat this SAE, Serious adverse event - Surgical treatment for this SAE, SAE - Description, SAE - Comments, Investigator signature
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, GENERAL MEDICAL HISTORY, PHYSICAL EXAMINATION, LABORATORY TESTS, VACCINE ADMINISTRATION, VACCINE ADMINISTRATION 2, VACCINE ADMINISTRATION 3, VACCINE NON-ADMINISTRATION, ADVERSE EVENTS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS, LOCAL SYMPTOMS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS (vaccine specific), DTPw-HBV Kft. vaccine, Hiberix™ vaccine, SOLICITED ADVERSE EVENTS – GENERAL SYMPTOMS, GENERAL SYMPTOMS
- Vaccines
- Physical Examination
- Drug-Related Side Effects and Adverse Reactions
- Clinical Trial
- Adverse event
- Hepatitis B Vaccines
- Haemophilus influenzae type b
- Clinical Trial, Phase III
- Fever
- Diphtheria-Tetanus-Pertussis Vaccine
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Hepatitis B
- Meningitis, Haemophilus
- Signs and Symptoms
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, VACCINE ADMINISTRATION, VACCINE ADMINISTRATION 2, VACCINE ADMINISTRATION 3, VACCINE NON-ADMINISTRATION, ADVERSE EVENTS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS, LOCAL SYMPTOMS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS (vaccine specific), DTPw-HBV Kft. vaccine, Hiberix™ vaccine, SOLICITED ADVERSE EVENTS – GENERAL SYMPTOMS, GENERAL SYMPTOMS
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, GENERAL MEDICAL HISTORY, PHYSICAL EXAMINATION, LABORATORY TESTS, VACCINE ADMINISTRATION, VACCINE ADMINISTRATION 2, VACCINE ADMINISTRATION 3, VACCINE NON-ADMINISTRATION, ADVERSE EVENTS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS, LOCAL SYMPTOMS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS (vaccine specific), DTPw-HBV Kft. vaccine, Hiberix™ vaccine, SOLICITED ADVERSE EVENTS – GENERAL SYMPTOMS, GENERAL SYMPTOMS
- Signs and Symptoms
- Clinical Trial
- Laboratories
- Hepatitis B Vaccines
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Drug-Related Side Effects and Adverse Reactions
- Haemophilus influenzae type b
- Diphtheria-Tetanus-Pertussis Vaccine
- Physical Examination
- Meningitis, Haemophilus
- Hepatitis B
- Clinical Trial, Phase III
- Vaccines
- Fever
- Adverse event
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, GENERAL MEDICAL HISTORY, PHYSICAL EXAMINATION, LABORATORY TESTS, VACCINE ADMINISTRATION, VACCINE ADMINISTRATION 2, VACCINE ADMINISTRATION 3, VACCINE NON-ADMINISTRATION, ADVERSE EVENTS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS, LOCAL SYMPTOMS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS (vaccine specific), DTPw-HBV Kft. vaccine, Hiberix™ vaccine, SOLICITED ADVERSE EVENTS – GENERAL SYMPTOMS, GENERAL SYMPTOMS
- Haemophilus influenzae type b
- Clinical Trial
- Physical Examination
- Clinical Trial, Phase III
- Adverse event
- Diphtheria-Tetanus-Pertussis Vaccine
- Signs and Symptoms
- Hepatitis B
- Hepatitis B Vaccines
- Meningitis, Haemophilus
- Drug-Related Side Effects and Adverse Reactions
- Vaccines
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Laboratories
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, GENERAL MEDICAL HISTORY, PHYSICAL EXAMINATION, LABORATORY TESTS, VACCINE ADMINISTRATION, VACCINE ADMINISTRATION 2, VACCINE ADMINISTRATION 3, VACCINE NON-ADMINISTRATION, ADVERSE EVENTS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS, LOCAL SYMPTOMS, SOLICITED ADVERSE EVENTS – LOCAL SYMPTOMS (vaccine specific), DTPw-HBV Kft. vaccine, Hiberix™ vaccine, SOLICITED ADVERSE EVENTS – GENERAL SYMPTOMS, GENERAL SYMPTOMS
- Hepatitis B
- Drug-Related Side Effects and Adverse Reactions
- Clinical Trial
- Vaccines
- Physical Examination
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Adverse event
- Hepatitis B Vaccines
- Diphtheria-Tetanus-Pertussis Vaccine
- Fever
- Haemophilus influenzae type b
- Laboratories
- Meningitis, Haemophilus
- Clinical Trial, Phase III
Item-grupper: Administrative data, CHECK FOR STUDY CONTINUATION, LABORATORY TESTS (GROUPS DTPW-HBV Kft + Hiberix™), LABORATORY TESTS (OTHERS GROUPS), Concomitant Vaccination, MEDICATION, NON-SERIOUS ADVERSE EVENTS, STUDY CONCLUSION, OCCURRENCE OF SERIOUS ADVERSE EVENT, ELIMINATION CRITERIA, WITHDRAWAL FROM STUDY, INVESTIGATOR'S SIGNATURE
Item-grupper: Visit 22 (Year 16) Follow-up, INFORMED CONSENT, DEMOGRAPHICS, Laboratory Tests, Visit 23 (Year 17) Follow-up, LABORATORY TESTS, Visit 24 (Year 18) Follow-up, LABORATORY TESTS, Visit 25 (Year 19) Follow-up, LABORATORY TESTS, Visit 26 (Year 20) Follow-up, LABORATORY TESTS, FOLLOW-UP STUDIES, INVESTIGATOR'S SIGNATURE, Reason for non participation, Tracking Document, Investigator's Signature
Item-grupper: Serious Adverse Event Report, Serious Adverse Event, Demographics Domain, Serious Adverse Event, Vaccines, Experimental drug, Information, Serious Adverse Event, Concomitant Agent, Serious Adverse Event, Disease, Serious Adverse Event, Pharmaceutical Preparations, Serious Adverse Event, Operative Surgical Procedures, Serious Adverse Event, Description, Investigator Signature, Serious Adverse Event, Comment, Investigator Signature
Item-grupp: Non-Serious Adverse Event
Item-grupper: Administrative data, Non-Serious Adverse Events, Non-Serious Adverse Events Data